Butterfly Network (BFLY) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Butterfly Network | 1.17 Bn | 1.04 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.28% |
| Dec 31, 2025 | -6.59% |
| Sep 30, 2025 | -13.39% |
| Jun 30, 2025 | -153.82% |
| Mar 31, 2025 | 13.48% |
| Dec 31, 2024 | 1.21% |
| Sep 30, 2024 | 40.92% |
| Jun 30, 2024 | 38.58% |
| Mar 31, 2024 | 54.70% |
| Dec 31, 2023 | -139.69% |
| Sep 30, 2023 | -18.96% |
| Jun 30, 2023 | -101.18% |
| Mar 31, 2023 | 3,117.13% |
| Dec 31, 2022 | 96.89% |
| Sep 30, 2022 | -1,027.26% |
| Jun 30, 2022 | -56.95% |
| Mar 31, 2022 | -101.45% |
| Dec 31, 2021 | 79.57% |
| Sep 30, 2021 | 381.32% |
| Jun 30, 2021 | 106.79% |
| Mar 31, 2021 | -239,103.17% |
| Dec 31, 2020 | 132.08% |
| Sep 30, 2020 | 51.75% |
| Jun 30, 2020 | -197.50% |